Advertisement
Canada markets closed
  • S&P/TSX

    21,875.79
    -66.41 (-0.30%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.24 (-0.12%)
     
  • CAD/USD

    0.7308
    -0.0003 (-0.05%)
     
  • CRUDE OIL

    81.93
    +0.39 (+0.48%)
     
  • Bitcoin CAD

    85,952.61
    +1,805.19 (+2.15%)
     
  • CMC Crypto 200

    1,304.58
    +2.51 (+0.19%)
     
  • GOLD FUTURES

    2,337.50
    -2.10 (-0.09%)
     
  • RUSSELL 2000

    2,047.69
    +9.35 (+0.46%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • NASDAQ

    17,732.60
    -126.10 (-0.71%)
     
  • VOLATILITY

    13.13
    +0.69 (+5.55%)
     
  • FTSE

    8,185.27
    +21.15 (+0.26%)
     
  • NIKKEI 225

    39,631.06
    +47.98 (+0.12%)
     
  • CAD/EUR

    0.6791
    -0.0029 (-0.43%)
     

Why United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks

Why United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks

There are two types of biotech stocks, says Dewey Steadman, who heads up investor relations for United Therapeutics.